Researchers at the University of São Paulo (USP) in Brazil have demonstrated for the first time that in COVID-19 patients an immune mechanism known as the inflammasome participates in activation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback